| Jessica M Crosson, MD | |
|
275 W Macarthur, Oakland, CA 94611-5641 | |
| (510) 752-1000 | |
| Not Available |
| Full Name | Jessica M Crosson |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 275 W Macarthur, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649358425 | NPI | - | NPPES |
| 00G540050 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G54005 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica M Crosson, MD 275 W Macarthur, Oakland, CA 94611-5641 Ph: (510) 752-1000 | Jessica M Crosson, MD 275 W Macarthur, Oakland, CA 94611-5641 Ph: (510) 752-1000 |
News Archive
Genetic testing is a powerful diagnostic tool that is increasingly being used for the diagnosis of dilated cardiomyopathy, a disease in which the heart becomes enlarged, making it difficult to pump blood. Cardiomyopathy affects more than 3.5 million people in the United States.
Despite our remarkable advances in medicine and healthcare, the cure to cancer continues to elude us. On the bright side, we have made considerable progress in detecting several cancers in earlier stages, allowing doctors to provide treatments that increase long-term survival.
Biocept, Inc., a molecular diagnostics company commercializing and developing biomarkers to improve the detection and treatment of cancer, announces the launch of the CLIA-validated androgen receptor expression assay using a patient's blood for the detection and monitoring of late-stage prostate cancer and a certain form of breast cancer.
A complete clinical and genetic profile of a rare inherited disorder, steroid 11-hydroxylase deficiency, which can cause genital masculinization in females, is being reported by an international group of researchers led by investigators at the Icahn School of Medicine at Mount Sinai.
Genentech, a member of the Roche Group, today announced that the BREVACTA study of ACTEMRA (tocilizumab) given as a subcutaneous (SC) injection to patients with rheumatoid arthritis (RA) met its primary endpoint.
› Verified 2 days ago
Daniel Mantuani, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1506 4th Ave Apt 5, Apt 5, Oakland, CA 94606 Phone: 504-390-5474 | |
Jennifer I. Harris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Benjamin J. Bonnes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Richard J. Knight, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Michael S. Gelfond, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Dr. Kayla Enriquez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4564 | |
Dr. Emily Meilan Sze, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hawthorne Ave, Oakland, CA 94609 Phone: 510-869-2500 |